Written question asked by Rosena Allin-Khan (Labour) on Monday, 9 January 2017, in the House of Commons. It was due for an answer on Wednesday, 11 January 2017. It was answered by Baroness Blackwood of North Oxford (Conservative) on Tuesday, 17 January 2017 on behalf of the Department of Health.
Breast Cancer: Drugs
- Question
-
To ask the Secretary of State for Health, whether the National Institute for Health and Care Excellence (a) has met since 29 December 2016 or (b) plans to meet Roche during the consultation period for the Kadcyla form of trastuzumab emtansine.
- Answer
-
The National Institute for Health and Care Excellence has advised that there have been no such meetings since 29 December 2016 and that a meeting with Roche is in the process of being arranged.
Secondary information
- Type
- Written question
- Reference
- 59131
- Session
- 2016-17
- Subjects
- Breast cancer Drugs National Institute for Health and Care Excellence Roche
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2017-01-21 17:36:09 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/59131
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/59131
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/59131